Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution
Author:
Affiliation:
1. Monash Health Melbourne Australia
2. Olivia Newton‐John Cancer Research Institute Melbourne Australia
3. La Trobe University Melbourne Australia
4. Monash University Melbourne Australia
5. The Alfred Hospital Melbourne Australia
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1465
Reference37 articles.
1. The changing landscape of phase I trials in oncology;Wong KM;Nat Rev Clin Oncol,2016
2. Phase I trials as valid therapeutic options for patients with cancer;Adashek JJ;Nat Rev Clin Oncol,2019
3. Clinical development success rates for investigational drugs;Hay M;Nat Biotechnol,2014
4. Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience;Molife L;Ann Oncol,2012
5. Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents;Han C;Br J Cancer,2003
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survival outcomes in older adults undergoing early phase clinical trials;Journal of Geriatric Oncology;2024-05
2. Differences in cancer clinical trial activity and trial characteristics at metropolitan and rural trial sites in Victoria, Australia;Australian Journal of Rural Health;2024-04-17
3. Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital;JAMA Network Open;2023-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3